Skip to main content
Erschienen in:

21.08.2023 | Interventional Radiology

Predicting successful ultrasound-guided biopsy of liver lesions

verfasst von: Yarab Al Bulushi, Cinthia Cruz-Romero, Hadiseh Kavandi, Alexander Brook, Olga R. Brook

Erschienen in: Abdominal Radiology | Ausgabe 11/2023

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To determine the factors that affect successful ultrasound-guided biopsy of liver lesions and build a model predicting feasibility of US-guided liver biopsy.

Methods

This is IRB-approved HIPAA-compliant retrospective review of consecutive ultrasound-guided targeted liver biopsies performed or attempted between 1/2018 and 9/2020 at a single tertiary academic institution with a total of 501 patients included. Mann–Whitney and chi-square tests were used to compare continuous and categorical variables, respectively. Logistic regression model was built to predict feasibility of successful ultrasound-guided biopsy.

Results

Liver lesion biopsy was successfully performed with US guidance in 429/501 (86%) patients. Lesions not amenable for US biopsy were smaller (median size 1.6 cm vs 3.3 cm, p < 0.0001) and deeper within the liver (median depth 9.0 cm vs 5.8 cm, p < 0.0001). The technical success rate was lowest for lesions in segment II (40/53, 75%), while lesions in segment IVb (87/91, 96%) had highest success rate (p < 0.003). US targeting in patients with 1 or 2 lesions was less feasible than in patients with 3 or more lesions, 126/180 (70%) vs. 303/321 (94%), (p < 0.0001). Model including lesion size, depth, location, and number of lesions predicts feasibility of US-guided biopsy with Area under the ROC curve (AUC) = 0.92.

Conclusions

Linear logistic regression model that includes lesion size, depth and location, and number of lesions is highly successful in predicting feasibility of ultrasound-guided biopsy for liver lesions. Smaller lesions, deeper lesions, and lesions in segment II and VIII in patients with less than 3 lesions were less feasible for ultrasound-guided biopsy of liver lesions.

Graphical abstract

Literatur
1.
Zurück zum Zitat Khalifa, A., R. Sasso, and D.C. Rockey, Role of Liver Biopsy in Assessment of Radiologically Identified Liver Masses. Digestive Diseases and Sciences, 2022. 67(1): p. 337-343.CrossRefPubMed Khalifa, A., R. Sasso, and D.C. Rockey, Role of Liver Biopsy in Assessment of Radiologically Identified Liver Masses. Digestive Diseases and Sciences, 2022. 67(1): p. 337-343.CrossRefPubMed
2.
Zurück zum Zitat Parente, F.V.C., et al., US-GUIDED PERCUTANEOUS CORE LIVER BIOPSY: ANALYSIS OF 171 CASES FROM A SINGLE ONCOLOGY SERVICE. Arq Gastroenterol, 2018. 55(3): p. 208-211.CrossRefPubMed Parente, F.V.C., et al., US-GUIDED PERCUTANEOUS CORE LIVER BIOPSY: ANALYSIS OF 171 CASES FROM A SINGLE ONCOLOGY SERVICE. Arq Gastroenterol, 2018. 55(3): p. 208-211.CrossRefPubMed
3.
Zurück zum Zitat Elsayes, K.M., et al., Diagnostic yield of percutaneous image-guided tissue biopsy of focal hepatic lesions in cancer patients: ten percent are not metastases from the primary malignancy. Cancer, 2011. 117(17): p. 4041-8.CrossRefPubMed Elsayes, K.M., et al., Diagnostic yield of percutaneous image-guided tissue biopsy of focal hepatic lesions in cancer patients: ten percent are not metastases from the primary malignancy. Cancer, 2011. 117(17): p. 4041-8.CrossRefPubMed
4.
Zurück zum Zitat Ma, X., et al., Success of image-guided biopsy for small (≤ 3 cm) focal liver lesions in cirrhotic and noncirrhotic individuals. J Vasc Interv Radiol, 2010. 21(10): p. 1539-47; quiz 1547. Ma, X., et al., Success of image-guided biopsy for small (≤ 3 cm) focal liver lesions in cirrhotic and noncirrhotic individuals. J Vasc Interv Radiol, 2010. 21(10): p. 1539-47; quiz 1547.
5.
Zurück zum Zitat Schullian, P., et al., Accuracy and diagnostic yield of CT-guided stereotactic liver biopsy of primary and secondary liver tumors. Computer Aided Surgery, 2011. 16(4): p. 181-187.CrossRefPubMed Schullian, P., et al., Accuracy and diagnostic yield of CT-guided stereotactic liver biopsy of primary and secondary liver tumors. Computer Aided Surgery, 2011. 16(4): p. 181-187.CrossRefPubMed
6.
Zurück zum Zitat Schmidt, A.J., et al., Diagnostic yield of MR-guided liver biopsies compared with CT- and US-guided liver biopsies. J Vasc Interv Radiol, 1999. 10(10): p. 1323-9.CrossRefPubMed Schmidt, A.J., et al., Diagnostic yield of MR-guided liver biopsies compared with CT- and US-guided liver biopsies. J Vasc Interv Radiol, 1999. 10(10): p. 1323-9.CrossRefPubMed
7.
Zurück zum Zitat Narvani, A.A., et al., Does image guidance improve accuracy of core needle biopsy in diagnosis of soft tissue tumours? Acta Orthop Belg, 2009. 75(2): p. 239-44.PubMed Narvani, A.A., et al., Does image guidance improve accuracy of core needle biopsy in diagnosis of soft tissue tumours? Acta Orthop Belg, 2009. 75(2): p. 239-44.PubMed
8.
Zurück zum Zitat Beland, M.D., et al., Optimizing modality selection for image-guided procedures: an analysis of the challenges to ultrasound guidance. Abdom Radiol (NY), 2016. 41(4): p. 590-9.CrossRefPubMed Beland, M.D., et al., Optimizing modality selection for image-guided procedures: an analysis of the challenges to ultrasound guidance. Abdom Radiol (NY), 2016. 41(4): p. 590-9.CrossRefPubMed
9.
Zurück zum Zitat Appelbaum, L., et al., Focal hepatic lesions: US-guided biopsy--lessons from review of cytologic and pathologic examination results. Radiology, 2009. 250(2): p. 453-8.CrossRefPubMed Appelbaum, L., et al., Focal hepatic lesions: US-guided biopsy--lessons from review of cytologic and pathologic examination results. Radiology, 2009. 250(2): p. 453-8.CrossRefPubMed
10.
Zurück zum Zitat Vadvala, H.V., et al., Image-Guided Percutaneous Omental and Mesenteric Biopsy: Assessment of Technical Success Rate and Diagnostic Yield. J Vasc Interv Radiol, 2017. 28(11): p. 1569-1576.CrossRefPubMed Vadvala, H.V., et al., Image-Guided Percutaneous Omental and Mesenteric Biopsy: Assessment of Technical Success Rate and Diagnostic Yield. J Vasc Interv Radiol, 2017. 28(11): p. 1569-1576.CrossRefPubMed
11.
Zurück zum Zitat Sainani, N.I., et al., Computed tomography-guided percutaneous biopsy of isoattenuating focal liver lesions. Abdominal Imaging, 2014. 39(3): p. 633-644.CrossRefPubMed Sainani, N.I., et al., Computed tomography-guided percutaneous biopsy of isoattenuating focal liver lesions. Abdominal Imaging, 2014. 39(3): p. 633-644.CrossRefPubMed
12.
Zurück zum Zitat Facciorusso, A., et al., Diagnostic Yield of Endoscopic Ultrasound-Guided Liver Biopsy in Comparison to Percutaneous Liver Biopsy: A Two-Center Experience. Cancers (Basel), 2022. 16(1):p. 51-57. Facciorusso, A., et al., Diagnostic Yield of Endoscopic Ultrasound-Guided Liver Biopsy in Comparison to Percutaneous Liver Biopsy: A Two-Center Experience. Cancers (Basel), 2022. 16(1):p. 51-57.
13.
Zurück zum Zitat Kim, J.S., et al., Utility and Safety of Repeated Ultrasound-Guided Core Needle Biopsy of Focal Liver Masses. J Ultrasound Med, 2018. 37(2): p. 447-452.CrossRefPubMed Kim, J.S., et al., Utility and Safety of Repeated Ultrasound-Guided Core Needle Biopsy of Focal Liver Masses. J Ultrasound Med, 2018. 37(2): p. 447-452.CrossRefPubMed
14.
Zurück zum Zitat Pasha, T., et al., Cost-effectiveness of ultrasound-guided liver biopsy. Hepatology, 1998. 27(5): p. 1220-6.CrossRefPubMed Pasha, T., et al., Cost-effectiveness of ultrasound-guided liver biopsy. Hepatology, 1998. 27(5): p. 1220-6.CrossRefPubMed
15.
Zurück zum Zitat Tian, G., et al., Complications After Percutaneous Ultrasound-Guided Liver Biopsy. Journal of Ultrasound in Medicine, 2020. 39(7): p. 1355-1365.CrossRefPubMed Tian, G., et al., Complications After Percutaneous Ultrasound-Guided Liver Biopsy. Journal of Ultrasound in Medicine, 2020. 39(7): p. 1355-1365.CrossRefPubMed
16.
Zurück zum Zitat Maheux, A., et al., Targeted and non-targeted liver biopsies carry the same risk of complication. Eur Radiol, 2019. 29(11): p. 5772-5783.CrossRefPubMed Maheux, A., et al., Targeted and non-targeted liver biopsies carry the same risk of complication. Eur Radiol, 2019. 29(11): p. 5772-5783.CrossRefPubMed
17.
Zurück zum Zitat Lubner, M.G., et al., Efficacy of percutaneous image-guided biopsy for diagnosis of intrahepatic cholangiocarcinoma. Abdominal Radiology, 2022. 47(8):2647-2657.CrossRefPubMed Lubner, M.G., et al., Efficacy of percutaneous image-guided biopsy for diagnosis of intrahepatic cholangiocarcinoma. Abdominal Radiology, 2022. 47(8):2647-2657.CrossRefPubMed
18.
Zurück zum Zitat Caserta, M.P., N. Dahiya, and H. Tchelepi, Contrast-Enhanced Ultrasound-Guided Interventions-The New Sheriff in Town?: A Case-Based Review of Problem Solving With Ultrasound Contrast. Ultrasound Q, 2020. 36(2): p. 91-101.CrossRefPubMed Caserta, M.P., N. Dahiya, and H. Tchelepi, Contrast-Enhanced Ultrasound-Guided Interventions-The New Sheriff in Town?: A Case-Based Review of Problem Solving With Ultrasound Contrast. Ultrasound Q, 2020. 36(2): p. 91-101.CrossRefPubMed
Metadaten
Titel
Predicting successful ultrasound-guided biopsy of liver lesions
verfasst von
Yarab Al Bulushi
Cinthia Cruz-Romero
Hadiseh Kavandi
Alexander Brook
Olga R. Brook
Publikationsdatum
21.08.2023
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 11/2023
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-023-04017-6

Neu im Fachgebiet Radiologie

Bald 5% der Krebserkrankungen durch CT verursacht

Die jährlich rund 93 Millionen CTs in den USA könnten künftig zu über 100.000 zusätzlichen Krebserkrankungen führen, geht aus einer Modellrechnung hervor. Damit würde eine von 20 Krebserkrankungen auf die ionisierende Strahlung bei CT-Untersuchungen zurückgehen.

Röntgen-Thorax oder LDCT fürs Lungenscreening nach HNSCC?

Personen, die an einem Plattenepithelkarzinom im Kopf-Hals-Bereich erkrankt sind, haben ein erhöhtes Risiko für Metastasen oder zweite Primärmalignome der Lunge. Eine Studie hat untersucht, wie die radiologische Überwachung aussehen sollte.

Statine: Was der G-BA-Beschluss für Praxen bedeutet

Nach dem G-BA-Beschluss zur erweiterten Verordnungsfähigkeit von Lipidsenkern rechnet die DEGAM mit 200 bis 300 neuen Dauerpatienten pro Praxis. Im Interview erläutert Präsidiumsmitglied Erika Baum, wie Hausärztinnen und Hausärzte am besten vorgehen.

Brustdichte nicht mit Multivitaminpräparat-Einnahme assoziiert

Der regelmäßige Gebrauch von Nahrungsergänzungsmitteln scheint nicht die mammografische Brustdichte zu erhöhen. In einer US-amerikanischen Studie jedenfalls ließ sich ein derartiger Zusammenhang nicht bestätigen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.